Argus upgrades Forest Labs (FRX) to buy, citing a strong product pipeline that includes...

|About: Forest Laboratories, Inc. (FRX)|By:, SA News Editor

Argus upgrades Forest Labs (FRX) to buy, citing a strong product pipeline that includes potential blockbuster Daliresp for treating pulmonary disease, hypertension drug Bystolic, plus its Teflaro antibiotic. Shares +1.2% premarket.